Clinical Trials for Carcinoma, Hepatocellular

Find clinical trials for carcinoma, hepatocellular. Discover research opportunities and treatment options in your area.

28 Active Trials Found

Showing 28 trials on this page

Page 1 of 2

Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion

NCT ID: NCT03727633

This clinical trial is studying a new treatment approach for liver cancer, specifically hepatocellular carcinoma (HCC), in patients who have cirrhosis (scarring of the liver) and are not candidates...

Recruiting

Phase: PHASE2 Type: interventional Locations: Montpellier, , France, Dijon, , France +3 more

A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

NCT ID: NCT04008797

This clinical trial is investigating a new treatment called E7386, which is being tested in combination with other cancer drugs for patients with solid tumors, including liver cancer, colorectal ca...

Recruiting

Phase: PHASE1 Type: interventional Locations: Charleston, South Carolina, United States, Los Angeles, California, United States +118 more

A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma

NCT ID: NCT07010497

This clinical trial is testing a new treatment approach for patients with advanced liver cancer, specifically a type called hepatocellular carcinoma (HCC). The study is looking at a combination of ...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Seoul, , Korea, Republic Of

National Liver Cancer Screening Trial

NCT ID: NCT06084234

The National Liver Cancer Screening Trial is a research study that aims to find out which method of screening is better for detecting liver cancer in patients with certain liver conditions. Specifi...

Recruiting

Phase: PHASE4 Type: interventional Locations: Ann Arbor, Michigan, United States, Minneapolis, Minnesota, United States +13 more

A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors

NCT ID: NCT06687941

This clinical trial is studying a new treatment called AST-201 for patients with certain advanced solid tumors that are positive for a marker known as GPC3. The main goals of the study are to see h...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of +2 more

Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

NCT ID: NCT03894917

This clinical trial is focused on understanding how advanced liver cancer, known as hepatocellular carcinoma (HCC), affects older adults, particularly those who cannot have surgery to remove the tu...

Recruiting

Type: observational Locations: San Antonio, Texas, United States

A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to Standard Therapy

NCT ID: NCT06742892

This clinical trial is investigating a new treatment called HLX43 for patients with advanced liver cancer, specifically hepatocellular carcinoma (HCC), who have not responded to standard therapies ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Hunan, Hunan, China

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

NCT ID: NCT06794073

This clinical trial is investigating a new treatment approach for patients with unresectable primary liver cancer, specifically hepatocellular carcinoma (HCC). The study combines several therapies,...

Not yet recruiting

Phase: NA Type: interventional

A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers

NCT ID: NCT06422403

This clinical trial is studying whether it is safe and effective to give certain cancer treatments, called immune checkpoint inhibitors (nivolumab, atezolizumab, and pembrolizumab), less frequently...

Recruiting

Phase: PHASE2 Type: interventional Locations: Singapore, , Singapore

A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients.

NCT ID: NCT06349980

This clinical trial is looking at new treatment options for patients with liver cancer, specifically a type called hepatocellular carcinoma. Researchers want to find out the best dosage and see how...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, , China

Mass Response of Tumor Cells As a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

NCT ID: NCT05461430

The TraveraRTGx clinical trial is studying a new way to help doctors choose the best treatment for patients with different types of cancer. The trial focuses on looking at tumor cells found in flui...

Recruiting

Type: observational Locations: Oakland, California, United States

A Study of PTX-9908 Injection for Non-resectable HCC with TACE

NCT ID: NCT03812874

This clinical trial is studying a new treatment called PTX-9908 Injection for patients with a type of liver cancer known as non-resectable hepatocellular carcinoma (HCC) that cannot be surgically r...

Recruiting

Phase: PHASE1 Type: interventional Locations: New Taipei City, , Taiwan

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

NCT ID: NCT05486572

The clinical trial titled "Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI" is exploring two different screening methods to detect liver cancer early in patients who have ...

Recruiting

Phase: NA Type: interventional Locations: Seattle, Washington, United States, Long Beach, California, United States +15 more

Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma

NCT ID: NCT06571396

This clinical trial is studying the safety and effectiveness of immunotherapy-based treatments for patients with hepatocellular carcinoma (HCC), which is a type of liver cancer. The researchers aim...

Recruiting

Type: observational Locations: Jinan, Shandong, China, Jinan, Shandong, China

Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection

NCT ID: NCT06454578

This clinical trial is studying a new combination treatment of Adebrelimab and Apatinib for patients with hepatocellular carcinoma (HCC), a type of liver cancer, who are at high risk of the cancer ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Jinan, Shandong, China

Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular Carcinoma

NCT ID: NCT06530784

This clinical trial is investigating a new treatment approach for patients with hepatocellular carcinoma, which is a type of liver cancer. The study aims to see how safe and effective a combination...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular Carcinoma

NCT ID: NCT06384950

This clinical trial is studying how a chatbot powered by artificial intelligence, called ChatGPT, can help patients with early-stage liver cancer, also known as hepatocellular carcinoma. The goal i...

Recruiting

Phase: NA Type: interventional Locations: Taipei, Beitou District, Taiwan

Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular Carcinoma

NCT ID: NCT06365034

This clinical trial is looking at a treatment called conversion therapy for patients with a type of liver cancer known as hepatocellular carcinoma (HCC) that cannot be removed by surgery. The goal ...

Recruiting

Type: observational Locations: Jinan, Shandong, China

Individualized Dosimetry for Holmium-166 Radioembolization in Patients With Unresectable Hepatocellular Carcinoma

NCT ID: NCT06302400

This clinical trial is studying a treatment called QuiremSpheres®, which are tiny beads containing a radioactive substance, to see how safe and effective they are for patients with hepatocellular c...

Recruiting

Phase: NA Type: interventional Locations: London, , United Kingdom

A Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.

NCT ID: NCT06205732

This clinical trial is studying how effective a combination of treatments is for patients with intermediate and advanced liver cancer. Specifically, it compares the standard treatment called TACE (...

Recruiting

Type: observational Locations: Jinan, Shandong, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions